Blood group antibodies are made by CD5+ and by CD5- B cells

Immunology and Cell Biology
N J WuttkeH Zola

Abstract

The B1 subset of B lymphocytes is associated with the production of low-affinity, polyspecific antibodies. B1 cells are generally recognized by their expression of CD5, and comprise the majority of neonatal B cells. The neonate responds to a restricted range of antigens, and generally makes low-affinity IgM antibody. Published data suggest that antibodies against the blood group antigens A and B are found occasionally in cord blood, and develop rapidly in infants as a result of cross-reactivity with bacterial carbohydrate antigens. This suggests that CD5+ B1 cells may be specialized to make antibodies against such carbohydrate antigens. In this study we evaluated the appearance of antibodies against the blood group (ABO) antigens in human infants, using reagents which specifically distinguish between IgM (made by the infant) and IgG (mainly of maternal origin) and immunofluorescence to detect low levels of antibody. Having established that antibody is always detectable by 8 months of age, and frequently much earlier, we developed a plaque assay to examine the phenotype of cells making antibody against blood group antigens. At 8 months of age, CD5+ and CD5- cells were both capable of making anti-blood group antibody.

References

May 4, 1992·Annals of the New York Academy of Sciences·A C Allison, Y Nawata
Feb 1, 1992·International Immunology·N M BhatN N Teng
Feb 1, 1992·The Journal of Pediatrics·F M Erkeller-YukselF Vanlangendonck
Jan 1, 1990·Scandinavian Journal of Immunology·P M LydyardD Isenberg
Jan 1, 1989·Advances in Immunology·T J Kipps
Aug 1, 1987·Biochemical Society Transactions·W M Watkins
Jul 1, 1969·The Journal of Clinical Investigation·G F Springer, R E Horton
Jan 1, 1969·The Journal of Pediatrics·T ThomaidisN Matsaniotis
Jan 1, 1968·Vox Sanguinis·A ChattorajA M Josephson
Jan 1, 1969·Scandinavian Journal of Haematology·P Toivanen, T Hirvonen
Jun 1, 1967·American Journal of Diseases of Children·T ThomaidisN Matsaniotis
Jan 1, 1981·Immunological Reviews·W E GathingsM D Cooper
Feb 1, 1995·Transfusion·G Garratty, P Arndt
May 1, 1961·The Journal of Clinical Investigation·S KOCHWAL R WASSERMAN

❮ Previous
Next ❯

Citations

Feb 23, 1999·Human Immunology·P J MacardleH Zola
Jan 23, 1999·Current Opinion in Hematology·P M LydyardP Y Youinou
Jul 31, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Richard B Freeman
Jul 16, 2015·Transfusion·Donald R Branch
Dec 25, 2015·Clinical Journal of the American Society of Nephrology : CJASN·William HoffmanGeetha Chalasani
Nov 1, 2017·World Journal of Gastroenterology : WJG·Eung Chang LeeSang-Jae Park
Jun 12, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yajun GengGuoxing Zheng
Mar 10, 1998·Immunology and Cell Biology·H Zola
Aug 6, 2020·Genes and Immunity·Katharina Kappler, Thierry Hennet
Aug 14, 2021·Laboratory Medicine·Nathanael SchooleyMoritz Stolla
Jun 21, 2019·Current Opinion in Organ Transplantation·Alexander J Gilbert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.